Capital Change Notice - Issue of Employee Share Rights

07 September 2022
Capital Change Notice

This notice is given under NZX Listing Rule 3.13.1 and relates to the unlisted Employee Share Rights to acquire ordinary shares in the Company (‘ESRs’) issued under the Fisher & Paykel Healthcare Employee Share Rights Plan (the ‘Employee Share Rights Plan’).

Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Unlisted ESRs to acquire ordinary shares in the Company issued under the Employee Share Rights Plan
ISIN Not applicable
Section 2: capital change details
Number issued 163,032
Nominal value (if any) Not applicable
Issue price No amount is payable for the grant of ESRs. One ESR will convert into one ordinary share at no cost after three years, provided the recipient remains an employee.
Nature of the payment Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products issued 163,032 ESRs to acquire ordinary shares representing approximately 0.02823% of the ordinary shares on issue
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue and specific authority for issue Issue of ESRs under the Employee Share Rights Plan to incentivise selected employees to grow the Company and to attract, motivate and retain key employees
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. 413,305 ESRs
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution dated 24 August 2022
Terms or details of the issue The ESRs will be issued on the terms of the ESR Plan in the form approved by the Board.
Date of issue 07 September 2022
Section 3: authority for this announcement
Name of person authorised to make this announcement
Raelene Leonard
Contact phone number +64 9 574 0110
Contact email address [email protected]
Date of release via MAP 07 September 2022

---

Announcement PDF